![5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile structure](/static/products/3028/302804-00-8.webp)
5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile
TL;DR: 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile (CAS 302804-00-8) is a chemical compound with molecular formula C22H12ClN7 and molecular weight 409.08 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile
Also Known As: 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile, 5-{[(2Z)-1-benzyl-2,3-dihydro-1H-1,3-benzodiazol-2-ylidene](cyano)methyl}-6-chloropyrazine-2,3-dicarbonitrile
| Molecular Formula | C22H12ClN7 |
|---|---|
| Molecular Weight | 409.08 g/mol |
| LogP | 4.19784 |
| Topological Polar Surface Area | 112.42 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Exact Mass | 409.08426 |
| Heavy Atoms | 30 |
| Complexity | 1293.787 |
Chemical Identifiers
| CAS Number | 302804-00-8 |
|---|---|
| SMILES | C1=CC=C(C=C1)CN\2C3=CC=CC=C3N/C2=C(/C#N)\C4=NC(=C(N=C4Cl)C#N)C#N |
Product Overview
5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile (CAS 302804-00-8), with molecular formula C22H12ClN7 and molecular weight 409.08 g/mol. IUPAC: 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile.
Chemical Property Profile of 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile
Property Insights of 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile
The XLogP value of 4.19784 indicates that 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 112.42 Ų falls within the moderate polarity range, balancing permeability and solubility for 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile. Following Lipinski's Rule of Five, 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile has 1 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile?
The CAS number of 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile is 302804-00-8.
What is the molecular formula of 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile?
The molecular formula of 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile is C22H12ClN7.
What is the molecular weight of 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile?
The molecular weight of 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile is 409.08 g/mol.
Where can I buy 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile?
You can request a quote for 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile?
Yes, KEHONG BIO provides custom synthesis services for 5-[(Z)-(3-benzyl-1H-benzimidazol-2-ylidene)-cyanomethyl]-6-chloropyrazine-2,3-dicarbonitrile and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.